Revolutionary cell therapy trial offers hope for untreatable autoimmune conditions
NCT ID NCT07490275
Summary
This early-stage study is testing the safety of a new cell therapy for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy involves modifying immune cells to target specific markers on harmful B cells. Researchers will enroll 9 adults with conditions like lupus, scleroderma, or vasculitis to see if this approach is safe and how the modified cells behave in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY/RELAPSED SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.